Sinopharm Medicine Holding’s Guangzhou Pharmaceutical Logistics Center Starts Operation
This article was originally published in PharmAsia News
Executive Summary
Sinopharm Medicine Holdings has recently begun operation of its largest and most comprehensive pharmaceutical logistics platform in Guangzhou, following its other centers in Beijing, Shanghai, Tianjin and Shenyang. The move marks the firm's logistics foray in southern China. The RMB 142 million center will focus on providing storage, maintenance, distribution and categorization of drugs for pharmaceutical manufacturers and distributors. The platform represents Guangdong's first such third-party medical logistics business. Tapping into the logistics facilities will help drug makers reduce costs, guarantee medicine quality and improve supervision level. (Click here for more - Chinese Language)
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.